Entero Therapeutics Inc.盘中异动股价大跌5.44%

市场透视2025-02-10

北京时间2025年02月10日23时29分，Entero Therapeutics Inc.（ENTO.us）股票出现异动，股价急速下挫5.44%。截至发稿，该股报0.520美元/股，成交量8778股，换手率0.18%，振幅3.62%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.90百万美元，每股收益-0.59美元，毛利-1336.00美元，市盈率0.04倍。机构评级方面，目前...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2510864800?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-02-10 23:29","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2510864800","market":"us","top_or_hot":-1,"title":"Entero Therapeutics Inc.盘中异动 股价大跌5.44%","media":"市场透视","content":"<div>\n<p>北京时间2025年02月10日23时29分，Entero Therapeutics Inc.（ENTO.us）股票出现异动，股价急速下挫5.44%。截至发稿，该股报0.520美元/股，成交量8778股，换手率0.18%，振幅3.62%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.90百万美元，每股收益-0.59美元，毛利-1336.00美元，市盈率0.04倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102329049880845b&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Entero Therapeutics Inc.盘中异动 股价大跌5.44%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEntero Therapeutics Inc.盘中异动 股价大跌5.44%\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-02-10 23:29 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102329049880845b&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年02月10日23时29分，Entero Therapeutics Inc.（ENTO.us）股票出现异动，股价急速下挫5.44%。截至发稿，该股报0.520美元/股，成交量8778股，换手率0.18%，振幅3.62%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.90百万美元，每股收益-0.59美元，毛利-1336.00美元，市盈率0.04倍。机构评级方面，目前...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102329049880845b&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102329049880845b&s=b","article_id":"2510864800","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502102329049880845b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2510864800","pubTimestamp":1739201344,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年02月10日23时29分，Entero Therapeutics Inc.股票出现异动，股价急速下挫5.44%。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2546.81%、1506.45%、953.64%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 ，振幅分别为69.83%、66.09%、50.50%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道疾病的靶向非系统性治疗。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","LENZ":"Therapeutics"},"translate_title":"Entero Therapeutics Inc. stock plunges 5.44% during intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ENTO":0.9,"LENZ":1},"content_text":"北京时间2025年02月10日23时29分，Entero Therapeutics Inc.（ENTO.us）股票出现异动，股价急速下挫5.44%。截至发稿，该股报0.520美元/股，成交量8778股，换手率0.18%，振幅3.62%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.90百万美元，每股收益-0.59美元，毛利-1336.00美元，市盈率0.04倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Entero Therapeutics Inc.股票所在的生物技术行业中，整体跌幅为0.16%。其相关个股中，Biodexa Pharmaceuticals Plc、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 (To Pur Com)、Neurosense Therapeutics Ltd C/Wts 10/11/2026 (To Pur Com)涨幅较大，Biodexa Pharmaceuticals Plc、Nls Pharmaceutics Ltd.、Ocean Biomedical, Inc.较为活跃，换手率分别为2546.81%、1506.45%、953.64%，振幅较大的相关个股有Ocean Biomedical, Inc.、Biodexa Pharmaceuticals Plc、Immatics N V C/Wts 01/07/2025 (To Pur Com)，振幅分别为69.83%、66.09%、50.50%。Entero Therapeutics Inc.公司简介：Entero Therapeutics Inc 是一家后期临床阶段的生物制药公司，专注于开发针对胃肠道(GI)疾病的靶向非系统性治疗。该公司的项目解决了胃肠道健康方面的重大未满足需求，包括:latiglutenase，一种已进入三期临床准备阶段的、可能是治疗乳糜泻的一流靶向口服生物治疗药物;capeserod，一种选择性5-HT4受体部分激动剂，用于胃轻瘫等适应症;adrulipase是一种重组脂肪酶，用于消化囊性纤维化和慢性胰腺炎外分泌胰腺功能不全患者的脂肪和其他营养物质。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2510864800","isCrawlerRequest":true}

Entero Therapeutics Inc.盘中异动 股价大跌5.44%

精彩评论

Entero Therapeutics Inc.盘中异动股价大跌5.44%